Hyperhomocysteinia is a risk factor for retinal venous occlusion: A case control study

被引:4
作者
Al Wadani, Fahad [1 ]
Khandekar, Rajiv [2 ]
Salim, Gigani [1 ]
Al Ali, Mohammed [1 ]
Ramzi, Salman [1 ]
机构
[1] Minist Hlth, Dept Ophthalmol, Al Jabr Eye & Ear Hosp, Al Hasa, Saudi Arabia
[2] Minist Hlth, Eye & Ear Hlth Care, Deaprtment Non Communicable Dis Control, Muscat, Oman
关键词
Homocysteine; retinal vein occlusion; visual impairment; THERMOLABILE MTHFR GENOTYPE; VEIN OCCLUSION; HOMOCYSTEINE CONCENTRATIONS; PLASMA HOMOCYSTEINE; HEART-DISEASE; POPULATION; METAANALYSIS; MUTATION; FOLATE; STROKE;
D O I
10.4103/0301-4738.111213
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: We evaluated the role of hyperhomocysteinemia as a risk factor for retinal vein occlusion (RVO) in Indian patients. Type of Study: Matched case control type of longitudinal study was conducted in 2006-2007. Materials and Methods: Two medical retina specialists examined the eyes having an event of RVO in the last 15 days. A similar number of eyes without RVO were also examined. The serum and urine homocysteine levels of these persons were tested. Matched pair analysis was carried out to determine the risk of RVO among those with hyperhomocysteinemia. Results: We included 20 cases of RVO and 20 age-and sex-matched persons without RVO. The risk of RVO was significantly higher in persons with hyperhomocysteinemia [difference of mean 31.62 mu mol/L (95% Confidence Interval 16.60-47.86), P = 2.1 x 10(-13)]. The mean urine homocysteine level among cases and controls was not statistically significant. There were 12 persons with hypertension in both cases and control groups. Conclusion: Hyperhomocysteinemia is a risk factor for RVO. Any list of investigations for a case of RVO should include total plasma homocysteine (tHcy) levels.
引用
收藏
页码:291 / 294
页数:4
相关论文
共 30 条
[1]   Hyperhomocysteinemia and retinal vascular occlusive disease [J].
Abu El-Asrar, AM ;
Gader, AGMA ;
Al-Amro, SA ;
Al-Attas, OS .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2002, 12 (06) :495-500
[2]  
Appel LJ, 2000, CIRCULATION, V102, P852, DOI 10.1161/01.CIR.102.8.852
[3]   Thermolabile MTHFR genotype and retinal vascular occlusive disease [J].
Cahill, M ;
Karabatzaki, M ;
Donoghue, C ;
Meleady, R ;
Mynett-Johnson, LA ;
Mooney, D ;
Graham, IM ;
Whitehead, AS ;
Shields, DC .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (01) :88-90
[4]   Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease [J].
Cahill, MT ;
Stinnett, SS ;
Fekrat, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (06) :1136-1150
[5]  
Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5
[6]   Homocysteine and retinal vein occlusion: A population-based study [J].
Chua, B ;
Kifley, A ;
Wong, TY ;
Mitchell, P .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (01) :181-182
[7]   Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].
Clarke, R ;
Collins, R ;
Lewington, S ;
Donald, A ;
Alfthan, G ;
Tuomilehto, J ;
Arnesen, E ;
Bonaa, K ;
Blacher, J ;
Boers, GHJ ;
Bostom, A ;
Bots, ML ;
Grobee, DE ;
Brattström, L ;
Breteler, MMB ;
Hofman, A ;
Chambers, JC ;
Kooner, JS ;
Coull, BM ;
Evans, RW ;
Kuller, LH ;
Evers, S ;
Folsom, AR ;
Freyburger, G ;
Parrot, F ;
Genst, J ;
Dalery, K ;
Graham, IM ;
Daly, L ;
Hoogeveen, EK ;
Kostense, PJ ;
Stehouwer, CDA ;
Hopknis, PN ;
Jacques, P ;
Selhub, J ;
Luft, FC ;
Jungers, P ;
Lindgren, A ;
Lolin, YI ;
Loehrer, F ;
Fowler, B ;
Mansoor, MA ;
Malinow, MR ;
Ducimetiere, P ;
Nygard, O ;
Refsum, H ;
Vollset, SE ;
Ueland, PM ;
Omenn, GS ;
Beresford, SAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022
[8]   Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease [J].
De Bree, A ;
Verschuren, WMM ;
Kromhout, D ;
Kluijtmans, LAJ ;
Blom, HJ .
PHARMACOLOGICAL REVIEWS, 2002, 54 (04) :599-618
[9]   Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion [J].
Di Crecchio, L ;
Parodi, MB ;
Sanguinetti, G ;
Iacono, P ;
Ravalico, G .
OPHTHALMOLOGY, 2004, 111 (05) :940-945
[10]   Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population [J].
Gao, Wei ;
Wang, Yu-Sheng ;
Zhang, Peng ;
Wang, Hai-Yan .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 244 (10) :1246-1249